H.R. 8828 · 117th Congress · House

FDA Ethics Act of 2022

Active· Referred to the Subcommittee on Health.
Introduced
Sep 14, 22
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

FDA Ethics Act of 2022

This bill establishes several requirements for entities that contract with the Food and Drug Administration (FDA) relating to conflicts of interest, including requiring contractors to disclose conflicts of interest on an ongoing basis and prohibiting the FDA from hiring consultants who simultaneously provide services to drug manufacturers or other entities that are regulated by the FDA.

Action Timeline

4
  1. SEP 15, 2022Committee

    Referred to the Subcommittee on Health.

  2. SEP 14, 2022IntroReferral

    Introduced in House

  3. SEP 14, 2022IntroReferral

    Introduced in House

  4. SEP 14, 2022IntroReferral

    Referred to the House Committee on Energy and Commerce.

Committees

2

Health Subcommittee

hsif14

Referred: Sep 15, 2022

Active

Energy and Commerce Committee

hsif00

Referred: Sep 14, 2022

Active